Dr. Mohamed Mosaad Salama

Post-doctoral Fellow
Mansoura University, Egypt

Highest Degree
M.D. in Neurotoxicology from Mansoura University, Egypt

My URL
https://livedna.org/20.6181

Share this Profile

Area of Interest:

Biomedical Sciences
Neurodegenerative Disorders
Regenerative Medicine
Stem Cells
Neurodegenaration

Selected Publications

  1. Teixeira, S., S. Machado, F. Paes, B. Velasques and J.G. Silva et al., 2013. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol. Disorders-Drug Targets, 12: 567-582.
    CrossRef  |  PubMed  |  

  2. Salama, M., T.F. Yuan, S. Machado, E. Murillo-Rodriguez and J.A. Vega et al., 2013. Co-enzyme Q10 to treat neurological disorders: Basic mechanisms, clinical outcomes and future research direction. CNS Neurol. Disorders-Drug Targets, 12: 641-664.
    CrossRef  |  PubMed  |  

  3. Salama, M., S.M. Farrag, S.A. Abulasrar, M.M. Amin and A. Abdel-Aziz et al., 2013. Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol. Disorders-Drug Targets, 12: 583-586.
    CrossRef  |  PubMed  |  

  4. Salama, M., B. Helmy, M. El-Gamal, A. Reda and A. Ellaithy et al., 2013. Role of l-thyroxin in counteracting rotenone induced neurotoxicity in rats. Environ. Toxicol. Pharmacol., 35: 270-277.
    CrossRef  |  Direct Link  |  

  5. Abou-Donia, M.B., M. Salama and M. Islam, 2013. Autoantibodies against cytoskeletal neuronal proteins in sera of arsenic-exposed subjects correlate with neurological symptoms. Toxicol. Environ. Chem., 95: 823-836.
    CrossRef  |  Direct Link  |  

  6. Salama, M., S.A.E.A. Eldakroury, D. ElTantawy, A.A. Ghanem, H. Abd Elghaffar, M. Elhusseiny and S. Gad Elhak, 2012. Regenerative effects of umbilical cord matrix cells (UCMCs) in a rodent model of rotenone neurotoxicity. Environ. Toxicol. Pharmacol., 34: 338-344.
    CrossRef  |  Direct Link  |  

  7. Salama, M., A. Ellaithy, B. Helmy, M. El-Gamal and D. Tantawy et al., 2012. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. CNS Neurol. Disorders-Drug Targets, 11: 836-843.
    CrossRef  |  

  8. Salama, M., 2012. Huwe1: A possible role in PD. Med. Hypotheses, 79: 419-419.
    CrossRef  |  Direct Link  |  

  9. Arias-Carion, O. and M. Salama, 2012. Reward-seeking behavior and addiction: Cause or cog? Curr. Drug Abuse Rev., 5: 178-189.
    CrossRef  |  PubMed  |  

  10. Salama, M. and O. Arias-Carion, 2011. Natural toxins implicated in the development of Parkinson's disease. Ther. Adv. Neurol. Disorders, 4: 361-373.
    CrossRef  |  Direct Link  |  

  11. Salama, M. and O. Arias-Carion, 2011. Colchicine as a promising drug for Parkinson's disease. Med. Hypotheses, 76: 150-150.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Arias-Carion, O. and M. Salama, 2011. Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease. Med. Hypotheses, 77: 312-313.
    CrossRef  |  PubMed  |  Direct Link  |  

  13. Gad Elhak, S., A.A.A. Ghanem, H. Abdelghaffar, S. Eldakroury and M. Salama, 2010. Parkinson's disease: Is it a toxic syndrome? Neurol. Res. Int. 10.1155/2010/103094.
    CrossRef  |  PubMed  |  Direct Link  |  

  14. Gad Elhak, S., A. Ghanem, H. Abdelghaffar, S. Eldakroury, D. ElTantawy, S. ElDosouky and M. Salama, 2010. The role of pramipexole in a severe Parkinson's disease model in mice. Ther. Adv. Neurol. Disorders, 3: 333-337.
    CrossRef  |  

  15. Salama, M., 2009. Lead and hypertension. High Blood Pressure Cardiovasc. Prev., 16: 83-85.
    CrossRef  |  Direct Link  |  

  16. Gad ElHak, S.A., A.M. El-Ghazali, M.M. Salama and A.Y. Aboelyazeed, 2009. Fatal suicide cases in Port Said city, Egypt. J. Forensic Legal Med., 16: 266-268.
    CrossRef  |  Direct Link  |  
Member since December, 2013